PNC Financial Services Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-912
| Closed | -$9.46K | – | 4607 |
|
|
2023
Q2 | $9.46K | Buy |
912
+186
| +26% | +$1.93K | ﹤0.01% | 3896 |
|
|
2023
Q1 | $5.87K | Buy |
+726
| New | +$5.87K | ﹤0.01% | 3983 |
|
|
2020
Q2 | – | Sell |
-84
| Closed | – | – | 3897 |
|
|
2020
Q1 | $0 | Hold |
84
| – | – | ﹤0.01% | 3871 |
|
|
2019
Q4 | $0 | Hold |
84
| – | – | ﹤0.01% | 3963 |
|
|
2019
Q3 | $0 | Hold |
84
| – | – | ﹤0.01% | 3972 |
|
|
2019
Q2 | $0 | Hold |
84
| – | – | ﹤0.01% | 3993 |
|
|
2019
Q1 | $0 | Hold |
84
| – | – | ﹤0.01% | 4011 |
|
|
2018
Q4 | $0 | Hold |
84
| – | – | ﹤0.01% | 4018 |
|
|
2018
Q3 | $2K | Sell |
84
-9,819
| -99% | -$234K | ﹤0.01% | 3929 |
|
|
2018
Q2 | $199K | Buy |
9,903
+1,835
| +23% | +$36.9K | ﹤0.01% | 2188 |
|
|
2018
Q1 | $142K | Buy |
8,068
+2
| +0% | +$35 | ﹤0.01% | 2364 |
|
|
2017
Q4 | $198K | Buy |
8,066
+166
| +2% | +$4.08K | ﹤0.01% | 2192 |
|
|
2017
Q3 | $204K | Sell |
7,900
-1,320
| -14% | -$34.1K | ﹤0.01% | 2133 |
|
|
2017
Q2 | $250K | Buy |
9,220
+1,900
| +26% | +$51.5K | ﹤0.01% | 2015 |
|
|
2017
Q1 | $218K | Buy |
7,320
+2,680
| +58% | +$79.8K | ﹤0.01% | 2079 |
|
|
2016
Q4 | $126K | Buy |
+4,640
| New | +$126K | ﹤0.01% | 2340 |
|